+1 800 987 6007
close x

3 May, 2019, by clincapture-client

It’s common knowledge that not all Electronic Data Capture systems are created equal. Some systems better suit simpler phase I studies, while others are more equipped to handle complex phase II & III studies. In the past it has been fairly common to use a more affordable provider for phase I studies and then switch once studies get more complex. Since phase II & III studies are crucial for the success of a product, Sponsors usually want to use a provider that they can trust to handle the complexity of the trial. If a company is launching their first product and cannot afford an expensive leading Electronic Data Capture system, it can be hard to find a provider that can handle these more complex studies. What if we told you that you don’t have to switch systems after phase I?

Fortunately, ClinCapture believes in working with customers beyond phase I. Our sleek Electronic Data Capture platform “Captivate®” is built to handle both easy and complex trials, meaning our customers can continue running their study on Captivate® and avoid the headache of opting for an expensive alternative or a system that does not have the advanced capabilities they need.

Features you may need per phase:

If you are running a phase I study, you are probably looking for an Electronic Data Capture system that offers intuitive build designs, fast database go-live times, and a low monthly cost. This phase also benefits from do-it-yourself mid study changes.

If you are running a larger phase II or III study, you will probably need an Electronic Data Capture system that is scalable and has more advanced features, such as Form Versioning, flexible Risk-Based Monitoring (RBM) and Advanced Reporting with Business Intelligence (BI) Tools to allow for customizable reports and cross-study reporting.

If you are running a late phase study, you may be more focused on patient reported outcomes and the long-term cost of the study. With ClinCapture you can take advantage of our flexible eCOA/ePRO module that send customizable surveys directly to patients, clinicians, or caregivers. Additionally, ClinCapture offers specialized pricing structures for these types of studies.

ClinCapture is a high-quality Electronic Data Capture solution that handles ALL study phases, complex or simple, at 20% the cost of leading competitors! Learn more about ClinCapture ’s comprehensive eClinical platform. You can request a consultation here to get started.

About the author

ClinCapture provides a powerful eClinical platform that enables sponsors and CROs to rapidly build and deploy studies, lower clinical trials costs, and streamline data capture processes. Offering a host of Private Clinical Cloud® solutions, ClinCapture ’s technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions. For more information, please visit ClinCapture .com or follow us at @ClinCapture .

No, You Don’t Have to Switch Systems After Phase I!

Up Next

  • Vibe with Scott Weidley: The Launch That’s Changing Healthcare Conversations

    19 February, 2025

    Vibe with Scott Weidley: The Launch That’s Changing Healthcare Conversations

    Podcasting has revolutionized how we consume content, and few embody this transformation like Host Scott Weidley. With his compelling mix of healthcare, technology, and culture, he isn’t just about delivering information—he is about starting meaningful conversations that push the industry forward. Now, with an exciting launch of his new podcast, Read more +
  • Emerging Trends in Precision Medicine: Integrating Epigenetics into Oncology

    29 May, 2024

    Emerging Trends in Precision Medicine: Integrating Epigenetics into Oncology

    Trends in Precision Medicine: Integrating Epigenetics into Oncology Precision medicine in oncology is continually evolving, with recent advances in epigenetics presenting new pathways for understanding and treating cancer more effectively. Epigenetics involves the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence — es
    Read more +
  • Integrating Digital Health into Cancer Care: A New Future in Oncology

    16 May, 2024

    Integrating Digital Health into Cancer Care: A New Future in Oncology

    Integrating Digital Health into Cancer Care: A New Future in Oncology The integration of digital health technologies into cancer care marks a significant advancement in the field of oncology, reshaping how treatments are administered, monitored, and optimized for patient benefit. From mobile apps to wearable devices, digital health tools are becoming integral in supporting cancer treatment and
    Read more +
Skip to content